Hartalega Holdings Bhd (5168)
Kuala Lumpur Exchange · Malaysia · prices in MYR · close of 19 Oct 2026
Key indicators
| Last close | MYR 1.090 |
|---|---|
| 52-week range | 0.789 – 1.361 |
| Return, 1 month / 3 months | −6.8% / +10.1% |
| Return, 1 year / 3 years | −9.4% / −43.1% |
| Trend | Uptrend |
| RSI (14) | 52 |
| Volatility (1 year) | 46.6% |
| Worst drawdown (1 year) | -36.7% |
| Average daily value traded | 10.48M MYR |
| Dividend yield | 1.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Hartalega Holdings is a Malaysian manufacturer of gloves, based in Selangor. The company makes nitrile gloves, including examination and surgical gloves, for the medical, healthcare and industrial markets. Its customers include hospitals, clinics, laboratories and distributors, and its products are exported to many countries around the world. Hartalega operates its own production facilities and develops its glove technology in house, focusing on thin, strong nitrile gloves for professional and everyday protective use.
Hartalega Holdings Bhd trades under the code 5168 on the Kuala Lumpur Exchange in Malaysia, with its price quoted in Malaysian ringgit (MYR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Hartalega Holdings Bhd (5168) trades on the Kuala Lumpur Exchange in Malaysia. It last closed at MYR 1.090 on 19 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 389 of 1,066 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 9.4% and over the last three months it rose 10.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Kuala Lumpur Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 4.4% | ||
| From 52-week high | -18.1% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 10.1% | ||
| 6-month return | -6.3% | ||
| 12-month return, skipping the last month | -2.8% | ||
| Risk (lower is better) | 40 · Weak | Volatile, with deep drawdowns. | |
| Volatility (1 year) | 46.6% | ||
| Worst drawdown (1 year) | -36.7% | ||
| Liquidity | 94 · Strong | Trades actively. | |
| Average daily value traded | 10.48M MYR | ||
| Zero-volume days | 5.0% | ||
| Income | 26 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.7% | ||
| Years with dividends | 4 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Risk (lower is better): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +5.8% |
|---|---|
| 1 month | −6.8% |
| 3 months | +10.1% |
| 6 months | −6.3% |
| 1 year | −9.4% |
| 3 years | −43.1% |
| 5 years | – |
Signals
| 50-day / 200-day average | 1.048 / 1.044 |
|---|---|
| Golden / death cross (60 days) | Golden, 2 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.056 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 May 2026 | MYR 0.0180 |
| 20 Dec 2024 | MYR 0.1085 |
| 26 Nov 2024 | MYR 0.0056 |
| 24 Sep 2024 | MYR 0.0035 |
| 14 Sep 2022 | MYR 0.0350 |
| 25 May 2022 | MYR 0.0350 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Kuala Lumpur Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.